Krebs von den Lungen-6 (KL-6), a high-molecular-weight glycoprotein, is frequently elevated in patients with cancer; however, its precise role in the clinical progression of breast cancer (BC) remains unclear. This evidence concerns the gene MUC1 and breast carcinoma.